Identification of histone deacetylase inhibitors with (arylidene)aminoxy scaffold active in uveal melanoma cell lines.
Identification of histone deacetylase inhibitors with (arylidene)aminoxy scaffold active in uveal melanoma cell lines.
复制标题
DOI:
10.1080/14756366.2020.1835883
复制
发表时间:
2021-12
影响因子:
5.6
通讯作者:
Orlandini E
中科院分区:
文献类型:
--
作者:
Nencetti S;Cuffaro D;Nuti E;Ciccone L;Rossello A;Fabbi M;Ballante F;Ortore G;Carbotti G;Campelli F;Banti I;Gangemi R;Marshall GR;Orlandini E
Uveal melanoma (UM) represents an aggressive type of cancer and currently, there is no effective treatment for this metastatic disease. In the last years, histone deacetylase inhibitors (HDACIs) have been studied as a possible therapeutic treatment for UM, alone or in association with other chemotherapeutic agents. Here we synthesised a series of new HDACIs based on the SAHA scaffold bearing an (arylidene)aminoxy moiety. Their HDAC inhibitory activity was evaluated on isolated human HDAC1, 3, 6, and 8 by fluorometric assay and their binding mode in the catalytic site of HDACs was studied by molecular docking. The most promising hit was the quinoline derivative VS13, a nanomolar inhibitor of HDAC6, which exhibited a good antiproliferative effect on UM cell lines at micromolar concentration and a capability to modify the mRNA levels of HDAC target genes similar to that of SAHA.
登录
查看更多内容
影响因子:
3.3
作者:
Grant C;Rahman F;Piekarz R;Peer C;Frye R;Robey RW;Gardner ER;Figg WD;Bates SE
通讯作者:
Bates SE
影响因子:
1
作者:
Levinzon, Louis;Madigan, Michele;Cherepanoff, Svetlana
通讯作者:
Cherepanoff, Svetlana
影响因子:
4.6
作者:
Dai W;Zhou J;Jin B;Pan J
通讯作者:
Pan J
影响因子:
14.8
作者:
Hai Y;Christianson DW
通讯作者:
Christianson DW
影响因子:
3
作者:
Pettersen, EF;Goddard, TD;Ferrin, TE
通讯作者:
Ferrin, TE